NHS dementia diagnosis to be “overhauled”
NHS England is to tackle “shockingly low” dementia diagnosis rates over the next two years, the health secretary Jeremy Hunt has announced.
Read MoreAuthor: Ben Adams
Data transparency “a very strange debate” says new Lilly head
The new head of Lilly UK believes that the clinical trial transparency agenda in the UK is a “very strange debate”.
Read MoreLipitor generics help NHS save £1m per day
The NHS has saved more than £350 million in the first 12 months after the patent expiration of Pfizer’s Lipitor last year.
Read MoreMyriad Genetics stock rises on Angelina Jolie surgery
US-based diagnostic firm Myriad Genetics’ stock has risen after Oscar-winning actress Angelina Jolie announced she had an operation to remove both her breasts after using the firm’s services.
Read MoreInnovation must become integral to NHS
The uptake, nurturing and spreading of innovation in the NHS must become an integral part of all healthcare professionals in England.
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
